ArticleFrontiers in immunology2026

Modular engineered outer membrane vesicles for synergistic cancer immunotherapy via PD-L1 blockade and epigenetic reprogramming.

Longxue Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.